News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Impact of TMB, PD-L1 , genomic features, and pneumonitis on CRT and durvalumab response in stage III NSCLC – João Alessi
Photo from João Alessi/Twitter
Jul 19, 2023, 18:03

Impact of TMB, PD-L1 , genomic features, and pneumonitis on CRT and durvalumab response in stage III NSCLC – João Alessi

Glad to share our paper recently published in Nature. In which, we report the impact of TMB, PD-L1 , genomic features, and pneumonitis on CRT and durvalumab response in stage III NSCLC. Collaboration b/w Dana-Farber and Memorial Sloan Kettering Radiation Oncology.

For article: Click here

Source: João Alessi/Twitter

cancer Dana-Farber Durvalumab João Alessi Memorial Sloan Kettering Radiation Oncology OncoDaily Oncology pneumonitis
Special Coverage
Science
Jan 26, 2025, 21:58
Nikolas Naleid: Excited to share our systematic review on pembrolizumab safety in GI cancers
Science
Jan 26, 2025, 21:58
David J. Benjamin: Why did sacituzumab govitecan fail in the TROPiCS-04 study for advanced urothelial carcinoma?
Science
Jan 26, 2025, 21:58
Fumiko Ladd Chino: Developing a simplified financial toxicity screening tool for use in clinical practice
Blog
Jan 26, 2025, 21:56
Wafaa M Rashed: Developing localized guidelines that reflect the continent's cultural, social and economic contexts
Blog
Jan 26, 2025, 21:56
Supriya Peshin: The most extraordinary team in GI oncology
Blog
Jan 26, 2025, 21:55
Razelle Kurzrock: Target Cancer National Molecular Tumor Board
Blog
Jan 26, 2025, 21:55
The current status of BCG and ways to accommodate the shortage
Blog
Jan 26, 2025, 21:55
Adjuvant chemotherapy vs Adjuvant CTRT in Gallbladder cancer
Blog
Jan 26, 2025, 21:55
Antonio D'Alessio: 9 year follow-up of adjuvant cell therapy for HCC at ASCOGI25
Blog
Jan 26, 2025, 17:30
Pan-RAS Inhibitor Shows Early, Deep Molecular Responses in PDAC
Blog
Jan 26, 2025, 17:23
Trisha Lal: Day 1 of ASCOGI25
Blog
Jan 26, 2025, 17:19
The role of social media in oncology presented by Prof. Gevorg Tamamyan